Scan to Download
One power score. Smarter investment decisions
Telomir Pharmaceuticals Inc
TELO1.530USD
+0.130+9.29%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
46.69MMarket Cap
LossP/E TTM
Telomir Pharmaceuticals Inc
1.530
+0.130+9.29%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2022Q4
FY2022Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
54.27%-696.45K
55.50%-863.13K
44.28%-605.81K
49.96%-1.00M
---1.52M
---1.94M
-325.04%-1.09M
-2331.29%-2.00M
---255.79K
---82.39K
Net income from continuing operations
-249.89%-5.07M
65.15%-2.18M
68.93%-2.90M
-246.56%-5.93M
---1.45M
---6.25M
-1814.86%-9.33M
-632.91%-1.71M
---487.10K
---233.50K
Other non-cash items
---1.00
----
-98.42%130.00K
-100.00%0.00
--0.00
--4.34M
--8.23M
--743.75K
----
----
Change in working capital
-294.10%-291.00K
-152.62%-58.99K
337.08%100.53K
111.74%123.13K
---73.84K
---23.35K
-90.06%23.00K
-794.31%-1.05M
--231.31K
--151.10K
-Change in prepaid expenses
17.34%12.90K
69.10%-30.32K
7689.60%19.47K
1186.81%10.47K
--10.99K
---98.09K
--250.00
---963.00
----
----
-Change in payables and accrued expense
-258.23%-303.90K
-138.36%-28.68K
256.29%81.06K
110.75%112.67K
---84.83K
--74.74K
-90.16%22.75K
-793.67%-1.05M
--231.31K
--151.10K
Cash from non-recurring investing activities
Cash from operating activities
54.27%-696.45K
55.50%-863.13K
44.28%-605.81K
49.96%-1.00M
---1.52M
---1.94M
-325.04%-1.09M
-2331.29%-2.00M
---255.79K
---82.39K
Investing cash flow
Cash from non-current investing activities
Financing cash flow
Cash flow from continuous financing activities
691.14%1.05M
----
-4.48%1.04M
-102.36%-46.91K
--132.44K
--5.21M
332.87%1.09M
2388.86%1.99M
--250.88K
--80.00K
Net cash flow from debt Issuance/repayment
----
----
----
-115.58%-132.44K
--132.44K
----
--1.83M
--850.00K
----
----
Net cash flow from common stock issuance/repurchase
--1.05M
----
1011.11%1.00M
--0.00
--0.00
--5.83M
--90.00K
--0.00
----
----
Proceeds from issuance of warrants
----
----
--37.30K
----
----
----
----
----
----
----
Net cash flow from other financing activities
----
----
100.00%1.00
-92.50%85.53K
--0.00
---620.48K
-433.26%-836.08K
1326.36%1.14M
--250.88K
--80.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
691.14%1.05M
----
-4.48%1.04M
-102.36%-46.91K
--132.44K
--5.21M
332.87%1.09M
2388.86%1.99M
--250.88K
--80.00K
Net cash flow
Beginning cash balance
-87.69%403.00K
102753.86%1.27M
33939.07%834.64K
12777.91%1.88M
--3.27M
--1.23K
-61.26%2.45K
--14.63K
--6.33K
--0.00
Current period cash flow changes
125.27%351.32K
-126.37%-863.13K
35439.31%431.49K
-8516.83%-1.05M
---1.39M
--3.27M
75.14%-1.22K
-408.43%-12.18K
---4.91K
---2.40K
Ending cash balance
-59.96%754.32K
-87.69%403.00K
102753.86%1.27M
33939.07%834.64K
--1.88M
--3.27M
-13.25%1.23K
202.38%2.45K
--1.42K
---2.40K
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
